Publicaciones en colaboración con investigadores/as de Aix-Marseille University (4)

2024

  1. Phase II Study to Determine the Antitumor Activity and Safety of Simlukafusp Alfa (FAP-IL2v) Combined with Atezolizumab in Esophageal Cancer

    Clinical Cancer Research, Vol. 30, Núm. 14, pp. 2945-2953

2014

  1. Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: Quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine

    Annals of Oncology, Vol. 25, Núm. 7, pp. 1428-1436

2013

  1. Adjuvant interferon alfa in malignant melanoma: An interdisciplinary and multinational expert review

    Critical Reviews in Oncology/Hematology, Vol. 85, Núm. 2, pp. 149-161

2012

  1. Dabrafenib in BRAF-mutated metastatic melanoma: A multicentre, open-label, phase 3 randomised controlled trial

    The Lancet, Vol. 380, Núm. 9839, pp. 358-365